Netherlands Heart Journal最新文献_第10页

Anticoagulation and thromboembolic risk in critically ill patients with trigger-induced atrial fibrillation-A systematic review and meta-analysis. 危重患者诱发性心房颤动的抗凝和血栓栓塞风险：系统回顾和荟萃分析

IF 2 4区医学

Netherlands Heart Journal Pub Date : 2025-10-01 Epub Date: 2025-08-28 DOI: 10.1007/s12471-025-01978-9

Jasper Koolwijk, Mileen van de Kar, Brittney A van der Woude, Marcel van 't Veer, Harm Jan de Grooth, Harry J G M Crijns, Lukas R C Dekker, R Arthur Bouwman, Olaf L Cremer, Ashley J R de Bie, Luuk C Otterspoor

{"title":"Anticoagulation and thromboembolic risk in critically ill patients with trigger-induced atrial fibrillation-A systematic review and meta-analysis.","authors":"Jasper Koolwijk, Mileen van de Kar, Brittney A van der Woude, Marcel van 't Veer, Harm Jan de Grooth, Harry J G M Crijns, Lukas R C Dekker, R Arthur Bouwman, Olaf L Cremer, Ashley J R de Bie, Luuk C Otterspoor","doi":"10.1007/s12471-025-01978-9","DOIUrl":"10.1007/s12471-025-01978-9","url":null,"abstract":"Introduction: In critically ill patients with trigger-induced atrial fibrillation, there are no definitive recommendations on the use of anticoagulation. This study aimed to evaluate the association between anticoagulation therapy and outcomes (i.e. thromboembolism, bleeding and mortality) and examine prescription patterns in high-risk individuals based on CHA2DS2-VASc scores.Methods: A systematic search was conducted to identify studies reporting on anticoagulation prescription, thromboembolism, bleeding, and mortality. Anticoagulation rates and CHA2DS2-VASc scores were correlated, and a meta-analysis was conducted to compare short- and long-term outcomes.Results: Anticoagulation prescription rates ranged from 3 to 86%; in over 50% of patients, CHA2DS2-VASc scores were ≥ 2 (n = 28 studies). A meta-analysis of eight observational studies, in which 95% of patients had sepsis/infection as the precipitant, demonstrated no association between anticoagulation and reduced short-term thromboembolism (OR 0.89, 95% CI 0.61-1.28) or increased bleeding (OR 1.05, 95% CI 0.90-1.22). Short-term mortality was lower in the anticoagulation group (OR 0.54, 95% CI 0.39-0.75), but a higher long-term thromboembolic risk was observed (OR 1.45, 95% CI 1.04-2.03).Conclusion: The prescription of anticoagulation in critically ill patients with TIAF is highly variable. There is no clear evidence of benefit or harm, and neither routine use nor systematic omission is supported.","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":" ","pages":"290-298"},"PeriodicalIF":2.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12454756/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144961960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Peculiar conduction. 特殊的传导。

IF 2 4区医学

Netherlands Heart Journal Pub Date : 2025-10-01 Epub Date: 2025-08-27 DOI: 10.1007/s12471-025-01977-w

Vladimir D C L'Espoir, Reinder Evertz, Rypko Beukema

引用次数: 0

Transforming echocardiography with artificial intelligence. 用人工智能改变超声心动图。

IF 2 4区医学

Netherlands Heart Journal Pub Date : 2025-10-01 Epub Date: 2025-09-05 DOI: 10.1007/s12471-025-01987-8

Robert M A van der Boon, Jacco C Karper

引用次数: 0

Peculiar conduction. 特殊的传导。

IF 2 4区医学

Netherlands Heart Journal Pub Date : 2025-10-01 Epub Date: 2025-08-27 DOI: 10.1007/s12471-025-01976-x

Vladimir D C L'Espoir, Reinder Evertz, Rypko Beukema

引用次数: 0

ENDOCOR: a nationwide consortium of endocarditis teams-initiating a registry for infective endocarditis within the Netherlands Heart Registration. ENDOCOR：一个全国性的心内膜炎团队联盟-在荷兰心脏注册中心启动感染性心内膜炎注册。

IF 2 4区医学

Netherlands Heart Journal Pub Date : 2025-10-01 Epub Date: 2025-09-03 DOI: 10.1007/s12471-025-01979-8

Annelot J L Peijster, Floris J Heinen, Sabrine Douiyeb, Michelle D van der Stoel, Jasper L Selder, Anouk G W Watson-de Lepper, Patrick Houthuizen, Matthijs F L Meijs, Linda M Kampschreur, Simon Schalla, Bhanu N M Sinha, Annelies L M Bakker, Ilse J E Kouijzer, Francisca Nijland, C H Edwin Boel, Robert K Riezebos, Mariëlle G J Duffels, Jesper Hjortnaes, Robert J M Klautz, Nelianne J Verkaik, Marco C Post, Steven A J Chamuleau, Otto Kamp, Wilco Tanis

{"title":"ENDOCOR: a nationwide consortium of endocarditis teams-initiating a registry for infective endocarditis within the Netherlands Heart Registration.","authors":"Annelot J L Peijster, Floris J Heinen, Sabrine Douiyeb, Michelle D van der Stoel, Jasper L Selder, Anouk G W Watson-de Lepper, Patrick Houthuizen, Matthijs F L Meijs, Linda M Kampschreur, Simon Schalla, Bhanu N M Sinha, Annelies L M Bakker, Ilse J E Kouijzer, Francisca Nijland, C H Edwin Boel, Robert K Riezebos, Mariëlle G J Duffels, Jesper Hjortnaes, Robert J M Klautz, Nelianne J Verkaik, Marco C Post, Steven A J Chamuleau, Otto Kamp, Wilco Tanis","doi":"10.1007/s12471-025-01979-8","DOIUrl":"10.1007/s12471-025-01979-8","url":null,"abstract":"Background: Despite advancements in diagnostics and treatment strategies, infective endocarditis continues to carry a substantial morbidity and mortality risk. In addition, the field of infective endocarditis contains many gaps in evidence, as international guidelines are predominantly based on low-level evidence. To improve infective endocarditis care and survival rates in the Netherlands, adequate evaluation of diagnostics, treatment strategies and outcomes is essential.Methods: To address this need, a new infective endocarditis registry has been developed by the multidisciplinary ENDOCOR working group with the aim of facilitating nationwide quality control, improving infective endocarditis patient care, and contributing to the numerous gaps in evidence. To optimize data collection, facilitated by the Netherlands Heart Registration (NHR), a pilot project was launched in January 2023 across three selected hospitals.Results: The findings from the first 150 registered patients were presented to highlight the registry's potential. Following the pilot, many more centres have initiated data collection, demonstrating national engagement and scalability of the initiative.Conclusion: This article outlines the purpose of ENDOCOR, presents initial pilot data and illustrates the potential of the new national infective endocarditis registry to enhance patient care and support future research.","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":" ","pages":"299-306"},"PeriodicalIF":2.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12454838/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144961922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Making a difference: describing and evaluating the impact of the Dutch CardioVascular Alliance. 做出改变：描述和评估荷兰心血管联盟的影响。

IF 2 4区医学

Netherlands Heart Journal Pub Date : 2025-10-01 Epub Date: 2025-08-14 DOI: 10.1007/s12471-025-01975-y

Sopany Saing, Jolien W Roos-Hesselink, Astrid Schut, Thea van Asselt, Rebecca Abma-Schouten, Margien G S Boels, Naomi Tramper, Clara van Ofwegen-Hanekamp, Robert Willemsen, Michelle M A Kip, Hendrik Koffijberg

{"title":"Making a difference: describing and evaluating the impact of the Dutch CardioVascular Alliance.","authors":"Sopany Saing, Jolien W Roos-Hesselink, Astrid Schut, Thea van Asselt, Rebecca Abma-Schouten, Margien G S Boels, Naomi Tramper, Clara van Ofwegen-Hanekamp, Robert Willemsen, Michelle M A Kip, Hendrik Koffijberg","doi":"10.1007/s12471-025-01975-y","DOIUrl":"10.1007/s12471-025-01975-y","url":null,"abstract":"Introduction: In 2018, the Dutch CardioVascular Alliance (DCVA), a collaboration between 24 partners in the cardiovascular field, expressed the ambition to reduce the cardiovascular disease (CVD) burden in the Netherlands by 25% in 2030. This project aimed to evaluate the extent to which the activities within the DCVA contribute to a reduction in the burden defined as morbidity and mortality combined.Methods: The role and potential impact of the DCVA was assessed. Three assessments were conducted: 1) to determine the potential impact of consortia (n = 32) using a checklist; 2) to estimate the potential health benefit (quality-adjusted life years, (QALYs)) and cost savings from a snapshot of consortia (n = 4).Results: Most of the consortia focused on treatment (31%), followed by secondary prevention/monitoring (23%) and diagnosis (23%). Almost all consortia (n = 31) aim to reduce morbidity and two-thirds (n = 21) aim to reduce mortality. The four consortia evaluated were Check@Home, LoDoCo2, CONTRAST 2.0 and IMPRESS, with pathways in screening, treatment, treatment and diagnosis, respectively. The total estimated cumulative QALYs gained (from 2023 to 2030) were 1,694, 362, 2,783, and 3,655 respectively.Discussion: Although it is impossible to estimate the full impact of the DCVA itself, the presented checklist and analyses may increase awareness of the different DCVA activities, roles, and consortia. Existing HTA methods can support the exploration of the potential impact generated by each consortium within the DCVA. The current portfolio of DCVA consortia contributes extensively to the DCVA goal of reducing the CVD burden, provided there is effective support for the adoption and implementation of innovations.","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":" ","pages":"307-312"},"PeriodicalIF":2.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12454727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144855850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Transforming cardiology with AI: the eko CORE 500 digital stethoscope. 用AI改变心脏病学：eko CORE 500数字听诊器。

IF 2 4区医学

Netherlands Heart Journal Pub Date : 2025-09-01 Epub Date: 2025-07-31 DOI: 10.1007/s12471-025-01973-0

Victor Umans

引用次数: 0

Timelines, targets, and transitions in cardiovascular care. 心血管护理的时间表、目标和转变。

IF 2 4区医学

Netherlands Heart Journal Pub Date : 2025-09-01 Epub Date: 2025-08-04 DOI: 10.1007/s12471-025-01984-x

Pim van der Harst

引用次数: 0

PENELOPE-CTRL: protocolised LDL-C lowering compared to real-world care in patients after myocardial infarction. PENELOPE-CTRL：与心肌梗死后患者的实际护理相比，协议化LDL-C降低。

IF 2 4区医学

Netherlands Heart Journal Pub Date : 2025-09-01 Epub Date: 2025-07-01 DOI: 10.1007/s12471-025-01964-1

Tinka van Trier, Aaram Omar Khader, Sander van der Brug, Anho Liem, Astrid Schut, Jan Tijssen, Fabrice Martens, Marco Alings

引用次数: 0

Hospital healthcare utilisation in patients with atrial fibrillation: the role of multimorbidity and age. 房颤患者的医院保健利用：多病和年龄的作用。

IF 2 4区医学

Netherlands Heart Journal Pub Date : 2025-09-01 Epub Date: 2025-07-18 DOI: 10.1007/s12471-025-01968-x

Melissa E Middeldorp, Colinda van Deutekom, Liann I Weil, Ursula W De Ruijter, Patrick T Jeurissen, Isabelle C Van Gelder, Barbara C van Munster, Michiel Rienstra

{"title":"Hospital healthcare utilisation in patients with atrial fibrillation: the role of multimorbidity and age.","authors":"Melissa E Middeldorp, Colinda van Deutekom, Liann I Weil, Ursula W De Ruijter, Patrick T Jeurissen, Isabelle C Van Gelder, Barbara C van Munster, Michiel Rienstra","doi":"10.1007/s12471-025-01968-x","DOIUrl":"10.1007/s12471-025-01968-x","url":null,"abstract":"Background: Patients with atrial fibrillation (AF) often present with multimorbidity and may require a higher healthcare utilisation. We aimed to compare hospital healthcare utilisation among AF patients to non-cardiovascular disease (non-CVD) patients and explore the role of multimorbidity and age.Methods: We performed a retrospective cohort study using electronic health records data from three hospitals in the Netherlands. Patients aged ≥ 18 years with ≥ 1 inpatient or outpatient presentation were included. Diagnoses were determined using the International Classification of Diseases and Related Health Problems 10 codes and linked with the Dutch Hospital Data Clinical Classification Software to determine comorbidities.Results: A total of 226,991 patients, 5,127 (2%) had AF. AF patients had significantly more outpatient visits (6.6 vs 3.6), emergency department visits (0.9 vs 0.2), and in-hospital days (4.0 vs 1.5) compared to non-CVD patients/year (all p < 0.001). AF patients saw more frequently multiple specialists, (13% vs 2% consulting ≥ 5 specialists, p < 0.001). Number of outpatient visits for AF patients increased with number of comorbidities: from a median of 1 (0-1 comorbidities) to 11 (≥ 4 comorbidities) (p < 0.001). Similarly, in-hospital days increased from 0.6 days (0-1 comorbidities) to 8.2 days (≥ 4 comorbidities) (p < 0.001). Regardless of age, AF patients had more outpatient and emergency department visits and more days in hospital days compared to non-CVD patients (all p < 0.001).Conclusions: Patients with AF had significantly greater hospital healthcare utilisation use compared to non-CVD patients, independent of age. Therefore, there is a need for more cohesive care pathways in AF patients to reduce healthcare utilisation.","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":" ","pages":"270-280"},"PeriodicalIF":2.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144659657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0